• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatrics . Two Distinct Illnesses Consistent With MIS-C in a Pediatric Patient

tetano

Editor, Senior Moderator
Pediatrics


. 2022 Apr 6;e2021053123.
doi: 10.1542/peds.2021-053123. Online ahead of print.
Two Distinct Illnesses Consistent With MIS-C in a Pediatric Patient


W Caleb Hancock[SUP] 1 2 [/SUP], Amanda M Green[SUP] 1 2 3 [/SUP], Caitlin Creel[SUP] 1 2 [/SUP], Sariha Moyen[SUP] 1 2 [/SUP], Kathleen P Collins[SUP] 1 2 [/SUP], Stephen D Pishko[SUP] 1 2 [/SUP], Terri H Finkel[SUP] 1 2 [/SUP], Bindiya Bagga[SUP] 1 2 [/SUP]



Affiliations

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a severe inflammatory response described in children after infection with severe acute respiratory syndrome coronavirus 2. We present a case of a 9-year-old African American boy with 2 distinct illnesses that were both consistent with MIS-C. He first presented in the early stages of our understanding of MIS-C with predominantly neurologic and gastrointestinal symptoms and demonstrated elevated inflammatory markers consistent with MIS-C. He was treated with intravenous immunoglobulin with complete resolution of signs and symptoms. After 7 months of good health, he returned with a second, distinct illness characterized by fever, rash, gastrointestinal symptoms, and elevated inflammatory markers that met the criteria for MIS-C. In addition, we identified new dilatation of the left anterior descending coronary artery. He improved rapidly after treatment with intravenous immunoglobulin, aspirin, and steroids. Our report highlights the need to achieve a better understanding of this entity's pathogenesis and clinical course and to improve anticipatory guidance for children with MIS-C.
 
Back
Top Bottom